Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Award
Common Stock
2025-02-27+72,000→ 165,546 total - Award
Stock Option (Right to Buy)
2025-02-27+50,000→ 50,000 totalExercise: $5.76Exp: 2035-02-26→ Common Stock (50,000 underlying)
Holdings
- 1,911.27(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted on February 27, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.